We are live on ! Find out more
BIOA.WS

BioAmber Inc.

Delisted

BIOA.WS was delisted on the 3rd of May, 2017.

9 hedge funds and large institutions have $2.26M invested in BioAmber Inc. in 2016 Q3 according to their latest regulatory filings, with funds opening new positions, 0 increasing their positions, 2 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

27% more capital invested

Capital invested by funds: $1.78M → $2.26M (+$478K)

10% less funds holding

Funds holding: 109 (-1)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 1

100% less repeat investments, than reductions

Existing positions increased: 0 | Existing positions reduced: 2

Holders
9
Holders Change
-1
Holders Change %
-10%
% of All Funds
0.24%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
2
Closed
1
Calls
Puts
Net Calls
Net Calls Change

Top Buyers

No buyers this quarter

BIOA.WS Hedge Fund Activity: Q3 2016 in Review

9 of the 3,748 institutional investors tracked by Wall St. Rank reported a position in BioAmber Inc. (BIOA.WS) for Q3 2016, worth a combined $2.26M — up 27% from $1.78M a quarter earlier.

Sellers outnumbered buyers: 1 fund closed out of BIOA.WS and 0 opened new positions — a net loss of 1 holder — while 2 trimmed existing stakes and 0 added.

The largest seller was Levin Capital Strategies, cutting an estimated $10.7K.

  • 9 institutional investors held BioAmber Inc. (BIOA.WS) as of Q3 2016, down from 10 in Q2 2016.
  • Funds reported $2.26M of BioAmber Inc. stock for Q3 2016, up 27% quarter-over-quarter.
  • 0 funds opened new BioAmber Inc. positions in Q3 2016 and 1 closed out, a net change of -1 holder.
  • The largest BioAmber Inc. seller in Q3 2016 was Levin Capital Strategies, an estimated $10.7K sold.

Based on aggregated 13F filings for Q3 2016.